Across TCGA pan-cancer cohorts, BRD7P4 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of BRD7P4’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where BRD7P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BRD7P4 is over-expressed in tumor, although a few such as PAAD and BRCA show the opposite, repressed pattern.

COAD, PAAD, and BRCA are the cancer types where BRD7P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BRD7P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.096	.009	6	view →
PAAD	All	All	−0.152	.028	2	view →
BRCA	All	IV	−0.075	.004	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: BRD7P4 RNA expression & survival · all BRD7P4 data types